Taysha Gene Therapies
TSHA
#5607
Rank
โ‚น114.29 B
Marketcap
โ‚น417.27
Share price
0.55%
Change (1 day)
215.04%
Change (1 year)

Market capitalization of Taysha Gene Therapies (TSHA)

Market cap: โ‚น114.29 Billion

As of January 2026 Taysha Gene Therapies has a market cap of โ‚น114.29 Billion. This makes Taysha Gene Therapies the world's 5607th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Taysha Gene Therapies from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น114.29 B-20.27%
2025โ‚น143.35 B365.94%
2024โ‚น30.76 B11.68%
2023โ‚น27.54 B135.91%
2022โ‚น11.67 B-65%
2021โ‚น33.36 B-54.48%
2020โ‚น73.29 B

End of Day market cap according to different sources

On Jan 19th, 2026 the market cap of Taysha Gene Therapies was reported to be:

โ‚น113.67 Billion
by Nasdaq info icon info icon
โ‚น113.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น106.18 B-7.10%๐Ÿ‡บ๐Ÿ‡ธ USA